Dr Camille Guillerey

Honorary Fellow

Mater Research Institute-UQ
Faculty of Medicine


Dr Camille Guillerey is a Senior Research Officer in the Cancer Immunotherapies laboratory at Mater Research. She leads a small team of 3 researchers and students.

Dr Guillerey completed her PhD in Immunology at the Pasteur Institute of Paris, France. In 2014, she moved to Australia to study Cancer Immunonology at QIMR Berghofer Medical Research Institute. Dr Guillerey joined Kristen Radford's laboratory at Mater Research in late 2018 to establish an independent research program investigating immune responses to hematological cancers.

Dr Guillerey's research is currently focused on Natural Killer cells, a population of immune cells that recognise and kill cancer cells. She aims to identify mechanisms that may prevent Natural Killer cells from eliminating cancer cells and apply these findings to develop new treatments for childhood leukemia.

Research Impacts

Dr Guillerey has authored 25 publications, and has received more than $900,000 in competitive funding from NHMRC, Cancer Australia, Cure Cancer Australia and the Children Hospital Foundation. Through this research, Dr Guillerey has made integral contributions to improve knowledge on immune responses to blood cancers. She identified the immune molecules TIGIT and CD137 as promising targets in immune multiple myeloma, an incurable blood cancer. Her research contributions have been recognized with her nomination as a finalist for the 2019 Women in Technology rising star award.


View all Publications


View all Supervision


Book Chapter

  • Guillerey, Camille and Smyth, Mark J. (2016). NK cells and cancer immunoediting. Natural killer cells. (pp. 115-145) edited by Eric Vivier, James Di Santo and Alessandro Moretta. Switzerland: Springer. doi: 10.1007/82_2015_446

Journal Article

Grants (Administered at UQ)

PhD and MPhil Supervision

Current Supervision

Completed Supervision